BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11819005)

  • 1. Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high dose lorazepam infusion therapy.
    Parker MG; Fraser GL; Watson DM; Riker RR
    Intensive Care Med; 2002 Jan; 28(1):81-4. PubMed ID: 11819005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation.
    Barnes BJ; Gerst C; Smith JR; Terrell AR; Mullins ME
    Pharmacotherapy; 2006 Jan; 26(1):23-33. PubMed ID: 16422667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propylene glycol-induced lactic acidosis in a patient with normal renal function: a proposed mechanism and monitoring recommendations.
    Neale BW; Mesler EL; Young M; Rebuck JA; Weise WJ
    Ann Pharmacother; 2005 Oct; 39(10):1732-6. PubMed ID: 16159998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions.
    Horinek EL; Kiser TH; Fish DN; MacLaren R
    Ann Pharmacother; 2009 Dec; 43(12):1964-71. PubMed ID: 19920159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity.
    Yahwak JA; Riker RR; Fraser GL; Subak-Sharpe S
    Pharmacotherapy; 2008 Aug; 28(8):984-91. PubMed ID: 18657015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute kidney injury, hyperosmolality and metabolic acidosis associated with lorazepam.
    Zar T; Yusufzai I; Sullivan A; Graeber C
    Nat Clin Pract Nephrol; 2007 Sep; 3(9):515-20. PubMed ID: 17717564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults.
    Arroliga AC; Shehab N; McCarthy K; Gonzales JP
    Crit Care Med; 2004 Aug; 32(8):1709-14. PubMed ID: 15286548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propylene glycol accumulation during continuous-infusion lorazepam in critically ill patients.
    Wilson KC; Farber HW
    J Intensive Care Med; 2008; 23(6):413; author reply 414-5. PubMed ID: 19019841
    [No Abstract]   [Full Text] [Related]  

  • 9. Propylene glycol-induced lactic acidosis in a patient receiving continuous infusion pentobarbital.
    Miller MA; Forni A; Yogaratnam D
    Ann Pharmacother; 2008 Oct; 42(10):1502-6. PubMed ID: 18698010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition, treatment, and prevention of propylene glycol toxicity.
    Zar T; Graeber C; Perazella MA
    Semin Dial; 2007; 20(3):217-9. PubMed ID: 17555487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osmolar gap metabolic acidosis in a 60-year-old man treated for hypoxemic respiratory failure.
    Arbour R; Esparis B
    Chest; 2000 Aug; 118(2):545-6. PubMed ID: 10936154
    [No Abstract]   [Full Text] [Related]  

  • 12. Propylene glycol toxicity related to high-dose lorazepam infusion: case report and discussion.
    Arbour RB
    Am J Crit Care; 1999 Jan; 8(1):499-506. PubMed ID: 9987548
    [No Abstract]   [Full Text] [Related]  

  • 13. Propylene glycol-associated renal toxicity from lorazepam infusion.
    Yaucher NE; Fish JT; Smith HW; Wells JA
    Pharmacotherapy; 2003 Sep; 23(9):1094-9. PubMed ID: 14524641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A life-threatening double gap metabolic acidosis.
    Tsao YT; Tsai WC; Yang SP
    Am J Emerg Med; 2008 Mar; 26(3):385.e5-6. PubMed ID: 18358977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe lactic acidosis after an iatrogenic propylene glycol overdose.
    Zosel A; Egelhoff E; Heard K
    Pharmacotherapy; 2010 Feb; 30(2):219. PubMed ID: 20099997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propylene glycol accumulation associated with continuous infusion of lorazepam in pediatric intensive care patients.
    Chicella M; Jansen P; Parthiban A; Marlowe KF; Bencsath FA; Krueger KP; Boerth R
    Crit Care Med; 2002 Dec; 30(12):2752-6. PubMed ID: 12483068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propylene glycol toxicity occurs during low-dose infusions of lorazepam.
    Arbour R
    Crit Care Med; 2003 Feb; 31(2):664-5; author reply 665. PubMed ID: 12576996
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of propylene glycol toxic reaction associated with etomidate infusion.
    Bedichek E; Kirschbaum B
    Arch Intern Med; 1991 Nov; 151(11):2297-8. PubMed ID: 1953236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe propylene glycol toxicity secondary to use of anti-epileptics.
    Pillai U; Hothi JC; Bhat ZY
    Am J Ther; 2014; 21(4):e106-9. PubMed ID: 22926232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propylene glycol ingestion causes D-lactic acidosis.
    Christopher MM; Eckfeldt JH; Eaton JW
    Lab Invest; 1990 Jan; 62(1):114-8. PubMed ID: 2296157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.